🔎 Trials Near Me

Dachaigh › Aillse a' bhroilleach › Oregon › Eugene

Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Eugene, OR

Tha 7 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Eugene (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

A’ fastadhÌre 3
  • Oncology Associates of Oregon PC, Eugene
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05827081

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

A’ fastadhÌre 3
  • Oncology Associates of Oregon, Eugene
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07174336

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A’ fastadhÌre 1/2
  • USOR Oncology Associates of Oregon, P.C., Eugene
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

A’ fastadhÌre 1/2
  • Oncology Associates of Oregon, Springfield · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT07558733

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

A’ fastadhSgrùdadh amharc
  • Willamette Valley Cancer Institute and Research Center, Eugene
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2025 · NCT03053193

Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile

Sgrùdaidhean eile ann an Eugene

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.